Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Forward Pharma A/S    FWP

FORWARD PHARMA A/S

(FWP)
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/11/2019 10/14/2019 10/15/2019 10/16/2019 10/17/2019 Date
0.99(c) 0.9347(c) 0.9843(c) 0.955(c) 0.92 Last
7 587 4 283 6 043 331 3 298 Volume
+3.57% -5.59% +5.31% -2.98% -3.66% Change
More quotes
Financials (USD)
Sales 2017 -
EBIT 2017 -
Net income 2017 -
Debt 2017 -
Yield 2017 -
Sales 2018 -
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018 -
Capi. / Sales2017 -
Capi. / Sales2018 -
Capitalization 45,4 M
More Financials
Company
Forward Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in the development of FP187, a formulation of dimethyl fumarate (DMF) for the treatment of several inflammatory and neurological indications, including multiple sclerosis (MS). The Company's clinical candidate,... 
More about the company
Latest news on FORWARD PHARMA A/S
09/05Forward Pharma to Participate in the Fall Investor Summit in New York
GL
06/26Forward Pharma A/S Announces Intention to Transfer its U.S. Public Listing to..
GL
04/04Forward Pharma Reports Financial and Operational Results from the Year Ended ..
GL
03/28FORWARD PHARMA A/S : to Participate in the DKBIO2019 Life Science Investor Confe..
AQ
03/27Forward Pharma to Participate in the DKBIO2019 Life Science Investor Conferen..
GL
2018FORWARD PHARMA A/S : Provides Update on the Decision of the Federal Circuit in i..
AQ
2018Forward Pharma Provides Update on the Decision of the Federal Circuit in its ..
GL
2018Forward Pharma to Participate in the Ladenburg Thalmann 2018 Healthcare Confe..
GL
2018Forward Pharma Reports Financial and Operational Results from the First Six M..
GL
2018Forward Pharma Appeals the Decision of the Opposition Division to Revoke the ..
GL
2018Forward Pharma to Present at the 7th Annual Leerink Partners Global Healthcar..
GL
2018Forward Pharma Announces the Decision of the European Patent Office in the Op..
GL
2017Forward Pharma Files Final Brief in its Appeal of the U.S. Patent Interferenc..
GL
2017Forward Pharma Files Further Written Submissions in the European Opposition P..
GL
2017Forward Pharma to Participate in Investor Conferences in December
GL
More news
News in other languages on FORWARD PHARMA A/S

- No features available -

More news
Analyst Recommendations on FORWARD PHARMA A/S
More recommendations
Sector news : Bio Therapeutic Drugs
08:29aGLOBAL MARKETS LIVE : Nestlé, Netflix, Huawei, General Motors…
10/16INCYTE : Says Phase 3 REACH2 Trial Meets Endpoint
DJ
10/15New Gilead Sciences CFO Expected to Pursue More Deals to Expand Portfolio
DJ
10/15GILEAD SCIENCES : Names Andrew Dickinson Chief Financial Officer
DJ
10/10GILEAD SCIENCES : Galapagos See Efficacy in Advanced Rheumatoid Arthritis Study
DJ
More sector news : Bio Therapeutic Drugs
Chart FORWARD PHARMA A/S
Duration : Period :
Forward Pharma A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FORWARD PHARMA A/S
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 0,96  $
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Claus Bo Svendsen CEO & Principal Financial Officer
Florian Schönharting Chairman
Torsten Rüdiger Goesch Director
Grant Hellier Lawrence Independent Director
Jakob Mosegaard Larsen Director
Sector and Competitors
1st jan.Capitalization (M$)
FORWARD PHARMA A/S22.44%45
GILEAD SCIENCES4.48%82 763
VERTEX PHARMACEUTICALS6.29%45 261
REGENERON PHARMACEUTICALS-19.84%32 761
WUXI APPTEC CO., LTD.65.00%20 165
GENMAB30.26%13 396